Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Magna International Inc. Common Stock (MGA) vs Merck & Co., Inc. (MRK) Price & Performance

Magna International Inc. Common StockTrade
Merck & Co., Inc.Trade

Price performance (Past 24H)

Key statistics

Magna International Inc. Common Stock vs Merck & Co., Inc. — how do they compare? Magna International Inc. Common Stock trades at $63.7 (market cap $17.04B), while Merck & Co., Inc. trades at $142.17 (market cap $351.28B). The key difference: Merck & Co., Inc. is far larger — about 20.6× Magna International Inc. Common Stock's market cap, and Magna International Inc. Common Stock pays the higher dividend (3.1%). Which is the better fit depends on your goals — on Pluang, investors hold Magna International Inc. Common Stock for 0 Days and Merck & Co., Inc. for 98 Days on average.

MGAMRK
Market Cap
$17.04B$351.28B
Volume
1,523,7847,969,665
Sector
Consumer CyclicalHealth
52-Week High
$73.05$156.43
52-Week Low
$43.54$82.49
Typical Hold Time
0 Days98 Days
Enterprise Value
$22.08B$398.04B
Dividend Yield
3.1%2.39%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Magna International Inc. Common Stock

No Aura AI signal available yet.

Merck & Co., Inc.

Merck (MRK) trades at $142.79, up 0.61% on the day, with a bearish technical signal despite beating earnings estimates in recent quarters. The company reported 2025 revenue of $65.01B and net income of $18.25B, with a high P/E ratio of 113.9 reflecting premium valuation. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, while institutional investors have been increasing stakes.

The outlook is mixed: strong analyst consensus (68% buy ratings) and a $158.78 price target suggest upside, but high valuation and bearish technicals pose near-term risks. Key opportunities include pipeline expansion via M&A; risks involve integration challenges and patent pressures.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MGA
100% Buy0% Sell
Avg holding period · 0 Days
MRK
18% Buy82% Sell
Avg holding period · 98 Days

Top news

Latest headlines on both assets

About Magna International Inc. Common Stock

Magna International Inc. is a Canada-based automotive supplier that designs, engineers, and manufactures vehicle systems and components, including body and chassis structures, seating, powertrain, and electronics, and provides complete-vehicle engineering and contract assembly, with manufacturing operations in 28 countries.

Read more on MGA →

About Merck & Co., Inc.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.

Read more on MRK →